chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my bivalent vaccine and just hours later, the lymph nodes in my neck began swelling and were painful to touch. I had body chills and aches with a high-grade fever of 101.7F. I had a cough and nasal congestion with a lot of drainage. I have completely lost my appetite. I've been taking DayQuil and Nyquil for my symptoms. I took two at-home COVID-19 tests on 12/20/2022 and both came back positive. I called my physician who prescribed me Paxlovid, but I haven't gone to pick to up the prescription. As of now, I'm feeling better than I was the day before, but my lymph nodes are still swollen and my nasal congestion/drainage is still bothering me.
Rash developed on the upper arm on day 13 after first dose. It?s pink and a bit warm to the touch. It?s about 2-3 inches in a diameter.
Discharge Provider: DO Primary Care Provider at Discharge: PA  Admission Date: 4/25/2023  Discharge Date: 4/27/2023   DISCHARGE DIAGNOSES: 1. COVID-19 infection 2. Acute hypoxemic respiratory failure, resolved 3. Type 2 diabetes mellitus 4. Benign essential hypertension 5. GERD 6. Hypomagnesemia  HOSPITAL COURSE: Patient is an 85-year-old female with history of type 2 diabetes mellitus, hypertension and GERD who presented with cough, sore throat, and generalized weakness.  In the ED, she was hypoxemic and placed on 2 L oxygen.  Her chest x-ray showed no acute infiltrates.  She tested positive for COVID-19.  She was admitted to the hospitalist service for generalized weakness and COVID-19 infection.   Upon admission, she was continued on supplemental oxygen.  She was started on Remdesivir for her COVID-19 as well as Decadron 6 mg daily.  Labs and vital signs remained stable, and she was able to be weaned off oxygen by the morning of 4/27.   She was seen by PT and OT, who felt she was appropriate for return to her independent living facility.   She was felt stable for discharge on 4/27/23.  She will be discharge on 3 more days of oral Decadron for COVID-19.  She should follow-up with her PCP in 1 week.
Sore throat dry; Loss of appetite; Fatigue; Feverish; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 13-Jun-2021 and was forwarded to Moderna on 13-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Sore throat dry), DECREASED APPETITE (Loss of appetite), FATIGUE (Fatigue) and PYREXIA (Feverish) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Jun-2021, the patient experienced OROPHARYNGEAL PAIN (Sore throat dry), DECREASED APPETITE (Loss of appetite), FATIGUE (Fatigue) and PYREXIA (Feverish). At the time of the report, OROPHARYNGEAL PAIN (Sore throat dry), DECREASED APPETITE (Loss of appetite) and PYREXIA (Feverish) was resolving and FATIGUE (Fatigue) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.     Concomitants were not reported. No treatment information was reported.   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up received on 14-06-2021 included reporter information and updated state.
This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58 year-old female patient received pneumococcal 13-val conj vac (dipht crm197 protein) (PNEUMOCOCCAL 13-VAL CONJ VAC (DIPHT CRM197 PROTEIN)), administration date 23May2020 (Batch/Lot number: unknown) at the age of 57 years as dose number unknown, single for immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: MIGRAINE (non-serious), outcome "unknown", described as "Migraines". No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Approx 90 mm diameter area of erythema, posterior arm over tricep with extension down to elbow. Slight edema.
Resident was transferred to the hospital on 10/21/22 due to a change in mental status, drowsiness, generalized weakness. Expired in the hospital on 11/10/22
4 INCHES BELOW THE INJECTION, RECTANGLE SHAPED, DEEP RED PATCH, SOMETIMES ITCHY, APPROXIMATELY 6 INCHES BY 3 INCHES. RESOLVING WITH DESOXIMETASONE CREAM.
Side effects; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Side effects). At the time of the report, VACCINATION COMPLICATION (Side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.  No treatment medication were provided.
Pt had hives on the abd & back 2 days /p the inject. Dr treated /w Benadryl. Pt returned in 1 wk voiced no complaints
Fever; body aches; rash on chest and stomach; rash on chest and stomach and swollen where rash is; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 31Mar2021 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive any concomitant medications. Allergies to medications, food, or other products was reported as Bo. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration in the left arm on 03Mar2021 (at the age of 60-years-old), as a single dose for COVID-19 immunisation. On 01Apr2021 at 00:00, the patient experienced fever, body aches, rash on chest and stomach and swollen where rash was. The events resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported events. The clinical outcome of the events fever, body aches, rash on chest and stomach and swollen where rash was were not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Information has been received from a mother of a 16 year old female patient with "cysts in her ovaries", and allergies to penicillin, sulfa, cefaclor (CECLOR) and erythromycin ethylsuccinate (+) sulfisoxazole acetyl (PEDIAZOLE) who on 29-NOV-2006 was vaccinated with HPV vaccine (yeast), "in her hip". There was no concomitant medication.  Subsequently, "within 2 to 3 days after receiving the injection." the patient developed "hot flushes", fainted, felt dizzy, and nausea. The patient was also "red and flushed" in her face since receiving the injection. The patient was experiencing the "hot flushes" almost every day. It was also reported that the patient had been vaccinated with Tdap "whooping cough" injection (manufacturer unknown) on 05-JAN-2007 and the patient experienced swelling, itching and "a knot" at the injection site for the last "two to three weeks." At the time of the report, the patient was reportedly not recovered.  Additional information has been requested.
On 08/10/2022, that morning as soon as I stood up I had a sharp pain from the knee all the way up.  I have not been to the doctor, but I have been walking with a cane. The next day the sharp pain happened again and stayed.  It felt as though someone had smashed my knee with a sledge hammer.
Slight headache; Left arm, near the injection site, is slightly sore, a pain level around 3-4/achiness; soreness and achiness at injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Left arm, near the injection site, is slightly sore, a pain level around 3-4/achiness; soreness and achiness at injection site) and HEADACHE (Slight headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     Concurrent medical conditions included Seasonal allergy (Occasional), Allergy to plants, Ragweed allergy and Hypercholesterolemia since 15-Oct-2018. Concomitant products included ATORVASTATIN from 15-Oct-2018 to an unknown date for Hypercholesteraemia.    On 11-Jan-2021 at 10:43 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021 at 1:10 PM, the patient experienced VACCINATION SITE PAIN (Left arm, near the injection site, is slightly sore, a pain level around 3-4/achiness; soreness and achiness at injection site). On 12-Jan-2021, the patient experienced HEADACHE (Slight headache). The patient was treated with IBUPROFEN (ADVIL LIQUI GELS) on 12-Jan-2021 at a dose of 200 mg. On 12-Jan-2021, HEADACHE (Slight headache) had resolved. On 12-Jan-2021 at 5:10 PM, VACCINATION SITE PAIN (Left arm, near the injection site, is slightly sore, a pain level around 3-4/achiness; soreness and achiness at injection site) had resolved.            The patient reported her headache lasted for a few hours despite caffeine intake.   This case was linked to MOD-2021-212871 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jun-2021: Follow-up information received on 07 JUN 2021 contain: Patient demographics were updated,medical history updated, concomitant medication and treatment information was updated. Event Headache was added. Outcome of the event Vaccination site pain was updated from Unknown to recovered; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded
Reaction to the Moderna vaccination; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Reaction to the Moderna vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Reaction to the Moderna vaccination). At the time of the report, VACCINATION COMPLICATION (Reaction to the Moderna vaccination) outcome was unknown.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No relevant concomitant medications were reported.  No treatment information was provided.; Sender's Comments: Very limited information regarding this event/s has been provided at this time.  Further information has been requested.
On 1/9/14 received call from school RN at 2:00 pm reporting patient complained of right arm itching, where vaccine was given, RN reported that the area was red and raised about the size of a half dollar coin and the patient had a temperature of 99.7 F.  RN also states patient reported having chills. At 4:30 pm on 1/9/14 child came to public health clinic where deputy director and RN's assessed patient who was found to have 5-7 cm area of raised redness, warm to the touch.  Patient referred to Urgent care for assessment and treatment.  Patient went to Urgent care the same day (1/9/14) and was referred to the local ER to have area drained.  Patient was placed on Clindamycin 300 mg 4 x a day and Tylenol with codeine #3 1-2 tabs Q 4-6 hours prn.  Follow-up call to school RN on 1/13/2014 at 10:00 am, School RN reports she assessed patient and reported that right arm area has improved with minimal to no redness and reports the child is taking the antibiotics.
Severe pain in left temple, dizziness immediately after vaccine.  10 days later intense redness, swelling and pain at injection site.
I developed spasms of both my hands around 1 AM on 04-12-21 while I was eating a late meal.  This persisted intermittently for the next hour or more.  The spasms involved the thenar and hypothenar  muscles of the hand
Site: Bruising at Injection Site-Medium, Site: Pain at Injection Site-Mild, Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Medium, Systemic: Headache-Medium, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)-
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. On an unknown date during 2014, the patient was inoculated with the ZOSTAVAX (lot number, dosage and route of administration not provided) at a pharmacy, for routine adult health maintenance and the intended purpose for the prevention of shingles. The ZOSTAVAX did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On an unknown date later in 2014, the patient was treated for symptoms of a blistering vesicular rash, which was diagnosed as herpes zoster, or shingles. The outcome of the events is unknown. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving zoster vaccine live for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
Pt recvd vax 26JUN92 c/o following sx on 1JUL92 lt shoulder joint sore, arthritic pain lt hip, lt fingers, both knees, numbness up arms, nervousness, shaky hands, insomnia, dry cotton mouth, can't digest food, has not voided today;
abdominal pain, diarrhea x 2 days, sweating, chills, dec appetite, nausea; abdominal discomfort  (tenderness) cont for several wks;
Within 2 hours - arm very sore. Nearly immobile. Fever - 101.00 - flu like systems. Aching/chills, lack of appetite. Lasted until Wed. A.M. (48 hrs.).
Second shot I felt really bad the whole weekend; This case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced feeling bad. On an unknown date, the outcome of the feeling bad was unknown.   It was unknown if the reporter considered the feeling bad to be related to Shingles vaccine.  Additional details were provided as follows: Age at vaccination was not reported. The age group was selected as adult as per vaccine indication. The patient got the 2nd shot and felt really bad the whole weekend. The patient had exposed twice in the past couple of months.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching) and BLOOD URINE PRESENT (last night started urinating blood and still going on) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included FOLIC ACID, LOVASTATIN, LOSARTAN, APIXABAN (ELIQUIS), METOPROLOL SUCCINATE and FESOTERODINE FUMARATE (TOVIAZ) for an unknown indication.    On 11-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced BLOOD URINE PRESENT (last night started urinating blood and still going on). On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Itching). At the time of the report, VACCINATION SITE PRURITUS (Itching) outcome was unknown and BLOOD URINE PRESENT (last night started urinating blood and still going on) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
This spontaneous report received from a patient via a Pfizer Inc, (other company) concerned a 58 year old female. The patient's height, and weight were not reported. The patient's concurrent conditions included: psoriatic arthritis, high blood pressure, Sjogren's syndrome, Raynaud's, migraines, and discoid lupus, and other pre-existing medical conditions included: The patient was not a pregnant at the time of report. The patient experienced drug allergy when treated with erythromycin. The patient received covid-19 vaccine ad26.cov2.s (Dose number in series: 1) (suspension for injection, route of admin not reported, batch number: 1808980 and expiry: Unknown) dose was not reported, dose 1, 1 in total, administered in left arm on 30-MAR-2021 for prophylactic vaccination. Age at time of vaccination 56 years old. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26.cov2.s (Dose number in series: 1). The patient received non-company suspect vaccine elasomeran (Moderna covid-19 vaccine) (Dose number in series: 2) (form of admin and route of admin were not reported, batch number: 939905 and expiry: Unknown) dose was not reported, dose 2, administered in left arm on 02-NOV-2021 for prophylactic vaccination. Age at time of vaccination 57 years old. Concomitant medications included amitriptyline, amlodipine, calcium pantothenate/choline/cyanocobalamin/nicotinamide/pyridoxine hydrochloride/riboflavin/thiamine hydrochloride, colecalciferol, folic acid, hydroxychloroquine, magnesium oxide, meloxicam, methotrexate, metoprolol succinate, riboflavin, and ubidecarenone. On an unspecified date, the patient experienced covid-19 which is coded as suspected covid-19 infection (Dose number in series: 2). On 28-JUN-2022, the patient received non-company suspect Paxlovid (form of admin, route of admin and batch number were not reported) dose was not reported, administered for an treatment of covid-19. On 30-JUN-2022, the patient experienced rash on left arm, rash was red raised bumps and described that there was no whiteheads or pustules, non-itchy and the bumps range in size from small (pinhead size) to a little less than a 1/4 (Dose number in series 2). On 01-JUL-2022, treatment medications included: diphenhydramine hydrochloride The action taken with covid-19 vaccine ad26.cov2.s, elasomeran (Moderna covid-19 vaccine) was not applicable, and with Paxlovid was withdrawn on 30-JUN-2022. The patient had not recovered from rash on left arm/rash was red raised bumps, and the outcome of suspected covid-19 infection was not reported. This report was non-serious.
I developed Shingles approximately 1 week after vaccine was administered.  My PCP placed me on 7-day antiviral course.  Still having itching and discomfort even after rashes cleared up.
This medically confirmed report (initial receipt 03-Dec-2013) concerns a 77 year old female patient. On the 07-Nov-2013, the patient received AFLURIA (batch number R52406). On an unspecified date, the patient experienced neuralgias and neuropathy in the injection arm ever since vaccination. The patient had trouble raising her arm. The patient sought medical attention via a physician office visit. She was prescribed unspecified medications for treatment. Outcome was reported as not recovered.
Pain, swelling and itchiness at injection site about a dollar coin in size. Fever of 100.4, body aches and shortness of breath.
This spontaneous report was received from an immunization coordinator referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions and concomitant medications was provided. On 27-NOV-2017, the patient was vaccinated with an improperly stored dose of ROTATEQ (lot # M043836 with an expiration date in 17-JUN-2018) orally for prophylaxis. The vaccine was exposed to temperature excursion of 28.1 degrees Celsius for 48 hours. Data logger was involved. There was no previous temperature excursion. No adverse effects were reported. Follow-up information has been received from the physician on 05-DEC-2017, referring to the 4 months old female patient. The patient had no brothers or sisters. There was no illness at time of vaccination. On 27-NOV-2017, the patient was vaccinated with ROTATEQ (lot # N005972). On the same day, the patient was vaccinated with other suspect therapies, including hib conj vaccine (unspecified carrier) (lot# UI804AA, intramuscular, at Right Vastus Laterali (RVL)), PEDIARIX (lot # 92443, intramuscular, RVL) and PREVNAR 13 (lot # S35326, intramuscular, Left Vastus Lateralis (LVL)).  The vaccines later found to have been stored outside of accepted temperature range due to faulty thermostat on fridge. On the same day, upper respiratory infection (URI) was evident at time of Well-Child Care (WCC). The next day (on 28-NOV-2017), the patient had elevated temperature maximum 101 (unit not provided), vomited one time and had some diarrhea. The patient was fussier next few days, and developed cold symptoms. They did not want to repeat the vaccines but would continue as usual schedule. There was no prescription drug treatment for the experienced required. The outcome of the events was unknown. The causality between the suspect therapies and the events was unknown.
Immediately following shot loss of consciousness and seizure like activity. Came out of it within 1 minutes then dizziness and nausea and tingling in both arms.